ABTIS
Welcome to the Brand page for “ABTIS”, which is offered here for Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, for treating cancer; drugs for medical purposes, for treating diabetes; drugs for medical purposes, for treating ocular disease; antibodies for medical purposes, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations;research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology;.
Its status is currently believed to be active. Its class is unavailable. “ABTIS” is believed to be currently owned by “AbTis Co., Ltd.”
| Owner: |
ABTIS CO., LTD.
Owner Details |
|---|---|
| Description: |
Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, for treating cancer; drugs for medical purposes, for treating diabetes; drugs for medical purposes, for treating ocular disease; antibodies for medical purposes, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations;Research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology;
|
| Categories: | PHARMACEUTICAL AGENTS AFFECTING METABOLISM |
